These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8505641)

  • 1. MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment.
    Ferner RE; Chaudhuri R; Bingham J; Cox T; Hughes RA
    J Neurol Neurosurg Psychiatry; 1993 May; 56(5):492-5. PubMed ID: 8505641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI abnormalities in neurofibromatosis type 1 (NF1): a study of men and mice.
    Rosenbaum T; Engelbrecht V; Krölls W; van Dorsten FA; Hoehn-Berlage M; Lenard HG
    Brain Dev; 1999 Jun; 21(4):268-73. PubMed ID: 10392751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of white matter lesions in neurofibromatosis type 1: MR findings.
    Sevick RJ; Barkovich AJ; Edwards MS; Koch T; Berg B; Lempert T
    AJR Am J Roentgenol; 1992 Jul; 159(1):171-5. PubMed ID: 1609692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Encephalic lesions in neurofibromatosis: clinical manifestations and typical magnetic resonance findings].
    Magnaldi S; White RM; Bryan RN
    Radiol Med; 1990 Dec; 80(6):796-807. PubMed ID: 2126389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological function and MRI abnormalities in neurofibromatosis type 1.
    Joy P; Roberts C; North K; de Silva M
    Dev Med Child Neurol; 1995 Oct; 37(10):906-14. PubMed ID: 7493724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis.
    Mirowitz SA; Sartor K; Gado M
    AJR Am J Roentgenol; 1990 Feb; 154(2):369-73. PubMed ID: 2105032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1.
    Hyman SL; Gill DS; Shores EA; Steinberg A; Joy P; Gibikote SV; North KN
    Neurology; 2003 Apr; 60(7):1139-45. PubMed ID: 12682321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
    Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
    J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis type 1 in children: MR imaging and follow-up studies of central nervous system findings.
    Menor F; Marti-Bonmati L; Arana E; Poyatos C; Cortina H
    Eur J Radiol; 1998 Jan; 26(2):121-31. PubMed ID: 9518221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurofibromatosis type I (NF1): peculiarities and complications].
    Pascual-Castroviejo I
    Rev Neurol; 1996 Sep; 24(133):1051-5. PubMed ID: 8755343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of brainstem gliomas in patients with neurofibromatosis 1.
    Pollack IF; Shultz B; Mulvihill JJ
    Neurology; 1996 Jun; 46(6):1652-60. PubMed ID: 8649565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of MRI abnormalities in children with neurofibromatosis.
    Duffner PK; Cohen ME; Seidel FG; Shucard DW
    Neurology; 1989 Mar; 39(3):373-8. PubMed ID: 2494565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning.
    Hyman SL; Gill DS; Shores EA; Steinberg A; North KN
    J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1088-91. PubMed ID: 17299016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is magnetic resonance spectroscopy capable of detecting metabolic abnormalities in neurofibromatosis type 1 that are not revealed in brain parenchyma of normal appearance?
    Rodrigues AC; Ferraz-Filho JR; Torres US; da Rocha AJ; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino ÉC
    Pediatr Neurol; 2015 Mar; 52(3):314-9. PubMed ID: 25585912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI findings in children with neurofibromatosis type 1: a prospective study.
    Van Es S; North KN; McHugh K; De Silva M
    Pediatr Radiol; 1996 Jul; 26(7):478-87. PubMed ID: 8662066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis.
    Mirowitz SA; Sartor K; Gado M
    AJNR Am J Neuroradiol; 1989; 10(6):1159-63. PubMed ID: 2512777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Lesions of the Corpus Callosum in Patients With Neurofibromatosis Type 1.
    Jandhyala NR; Garcia MR; Kim M; Yohay K; Segal D
    Pediatr Neurol; 2024 Jul; 156():66-71. PubMed ID: 38733856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and instrumental (magnetic resonance imaging [MRI] and multimodal evoked potentials) follow-up of brain lesions in three young patients with neurofibromatosis 1.
    Margari L; Presicci A; Ventura P; Maria Bacca S; Iliceto G; Medicamento N; Buttiglione M; Perniola T
    J Child Neurol; 2006 Dec; 21(12):1085-90. PubMed ID: 17156707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children.
    DeBella K; Poskitt K; Szudek J; Friedman JM
    Neurology; 2000 Apr; 54(8):1646-51. PubMed ID: 10762507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1.
    Terada H; Barkovich AJ; Edwards MS; Ciricillo SM
    AJNR Am J Neuroradiol; 1996 Apr; 17(4):755-60. PubMed ID: 8730197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.